A Multicenter Study of the Efficacy of Cerezyme in Testing Skeletal Disease in Patients With Type I Gaucher Disease.

Clinical trial NCT00365131 · COMPLETED

Trial details

NCT number: NCT00365131
Sponsor: Genzyme, a Sanofi Company
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Gaucher Disease Type I Cerebroside Lipidosis Syndrome Clucocerebrosidase Deficiency Disease Glucosylceramide Beta-Glucosidase Deficiency Disease Gaucher Disease, Non-Neuronopathic Form

Start date: 1997-12-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.